X

Elder Pharmaceuticals Ltd. Stock Analysis

Small Cap
Evaluated by 760 users | BSE: 532322 | NSE: ELDERPHARM |
Pharmaceuticals & Drugs
Elder Pharmaceuticals was incorporated in the year 1983 and commenced operations in 1989. The company is engaged into manufacturing and marketing of prescription pharmaceutical brands, surgical and medical devices.Elder is one the leading companies in the pharmaceutical formulation market in...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Jun'13Jun'14
Return on Capital Employed 9.87%11.86%12.55%13.27%10.08%10.23%9.9%10.28%11.06%-3.62%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 285355449551620703839985986483
Y-o-Y Gr. Rt.-24.4%26.6%22.7%12.5%13.4%19.3%17.4%0.2%-51%
Adjusted EPS (Rs.) 11.9921.0628.4436.5827.3531.2236.1943.1637.61-117.76
Y-o-Y Gr. Rt.-75.7%35%28.6%-25.2%14.2%15.9%19.3%-12.9%-413.1%
Book Value per Share (Rs.) 124.16146.26172.82203.86220.23251.7297.56336.82302.99382.51
Adjusted Net Profit 19.236.852.868.851.658.974.388.677.3-242
Net Op. Cash Flow (Rs. Cr.) -10.3-5.370.9-37.462.28.961.819.5-25.51,153
Debt to Cash Flow from Ops -12.81-37.643.33-9.126.4462.2212.1145.38-35.650.52
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Elder Pharmaceuticals Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 6%-4.9%-16.8%-51%
Adjusted EPS -228.9%-233.9%-248.2%-413.1%
Book Value per Share 13.311.78.726.3
Share Price -0.6% 25.6% 110.9% 837.8%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Jun'13Jun'14
Return on Equity (%) 12.6116.0818.1719.4112.8913.2313.6913.6113.14-30.94
Operating Profit Margin (%) 14.6917.1217.3819.1316.2618.4420.9720.5521.82-13.42
Net Profit Margin (%) 6.7210.3711.7612.478.328.388.8697.83-50.02
Debt to Equity 0.660.770.740.890.961.171.231.281.460.76
Working Capital Days 261243231212232250257281327755
Cash Conversion Cycle 148143132109117132137147122179
Entity Percentage Holding
Promoters 25.34%
Institutions 23.98%
Non-Institutions 50.67%
Pledged *99.4299.1795.3091.4989.9477.7377.5685.0684.7384.69
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Elder Pharma's performance infers:

Elder Pharma earnings have declined by -233.9%, whereas share price has appreciated 25.6% CAGR over the past five years, indicating the company's share price is likely overvalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Elder Pharma share prices over the last 10 years. Here is what we found out:

Elder Pharma share price has appreciated -1.4% annually over the past ten years.

Elder Pharmaceuticals was incorporated in the year 1983 and commenced operations in 1989. The company is engaged into manufacturing and marketing of prescription pharmaceutical brands, surgical and medical devices.

Elder is one the leading companies in the pharmaceutical formulation market in India. It holds market leader position in three therapeutic segments - Women’s Healthcare, Wound Care and Nutraceuticals.

Products

Elder manufactures API and formulations

Elder Pharmaceuticals was incorporated in the year 1983 and commenced operations in 1989. The company is engaged into manufacturing and marketing of prescription pharmaceutical brands, surgical and medical devices.

Elder is one the leading companies in the pharmaceutical formulation market in India. It holds market leader position in three therapeutic segments - Women’s Healthcare, Wound Care and Nutraceuticals.

Products

Elder manufactures API and formulations spread across 4 manufacturing plants in India and one in Nepal. It manufactures various dosage forms like tablets, capsules, syrups, injectables, topical creams and ointments.

It manufactures wide range of pharmaceutical brands such as Thrive G, Formic, Carnitor, Tanatril, B-long, Cranbe, Bonviva etc.

Company Shelcal brand is one of the top brands in the Indian pharmaceutical industry.

Awards

The company was awarded Amity Corporate Excellence Award for the year 2008

Elder was also honoured Frost & Sullivan Market Leadership Award for its 'Shelcal' brand for the year 2008.

It was among the Forbes list of 'Asia's 200 Best under a billion' over a period of three years.

It has subsidiary namely Elder International FZCO in Dubai, Somerta Holdings Company in Cyprus and Elder Biomeda EDA in Bulgaria.

In 2012 - Joint Managing Director Mr Alok Saxena has been bestowed with “Brand Slam Leadership Award” on 13th Oct, 2012 by Indira Group of Institutes, Pune.
- Elder Pharma is awarded India's Most Admired Nutrition and Neutraceutical Company of the Year 2012
-Elder Pharmaceuticals Limited is awarded with CIO100 Award.
-Elder Pharma join hands with Swedish firm Sterisol AB

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback